NCT00509600View on ClinicalTrials.gov

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Leukemia

Interventions

DRUG

Etanercept

0.8 mg/kg Subcutaneously Once A Week for 90 Days

Trial Locations (1)

77030

UT MD . Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER